Cazzola M - Search Results

1

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Ambaglio I, Malcovati L, Papaemmanuil E, Laarakkers CM, Della Porta MG, Gallì A, Da Vià MC, Bono E, Ubezio M, Travaglino E, Albertini R, Campbell PJ, Swinkels DW, Cazzola M. Ambaglio I, et al. Among authors: cazzola m. Haematologica. 2013 Mar;98(3):420-3. doi: 10.3324/haematol.2012.077446. Epub 2013 Jan 8. Haematologica. 2013. PMID: 23300182 Free PMC article.

2

Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.

Ponchio L, Beguin Y, Farina G, Pedrazzoli P, Pedrotti C, Poggi G, Rosti V, Bergamaschi G, Battistel V, Cazzola M. Ponchio L, et al. Among authors: cazzola m. Haematologica. 1992 Nov-Dec;77(6):494-501. Haematologica. 1992. PMID: 1289186 Clinical Trial.

3

Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system.

Cassano E, Giordano M, Riccardi A, Coci A, Cazzola M. Cassano E, et al. Among authors: cazzola m. Haematologica. 1990 Mar-Apr;75(2):141-5. Haematologica. 1990. PMID: 2358204

4

Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.

Cazzola M, Ponchio L, Pedrotti C, Farina G, Cerani P, Lucotti C, Novella A, Rovati A, Bergamaschi G, Beguin Y. Cazzola M, et al. Haematologica. 1996 Sep-Oct;81(5):434-41. Haematologica. 1996. PMID: 8952157 Free article.

5

A patient-oriented approach to treatment of myelodysplastic syndromes.

Cazzola M, Anderson JE, Ganser A, Hellström-Lindberg E. Cazzola M, et al. Haematologica. 1998 Oct;83(10):910-35. Haematologica. 1998. PMID: 9830800 Review.

6

Myelodysplastic syndromes: recent advances.

Alessandrino EP, Amadori S, Cazzola M, Locatelli F, Mecucci C, Morra E, Saglio G, Visani G, Tura S. Alessandrino EP, et al. Among authors: cazzola m. Haematologica. 2001 Nov;86(11):1124-57. Haematologica. 2001. PMID: 11694400 Review. No abstract available.

7

Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.

Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P. Cazzola M, et al. Blood. 2003 Mar 1;101(5):1996-2000. doi: 10.1182/blood-2002-07-2006. Epub 2002 Oct 24. Blood. 2003. PMID: 12406866 Free article.

8

Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.

Alessandrino EP, Amadori S, Barosi G, Cazzola M, Grossi A, Liberato LN, Locatelli F, Marchetti M, Morra E, Rebulla P, Visani G, Tura S; Italian Society of Hematology. Alessandrino EP, et al. Among authors: cazzola m. Haematologica. 2002 Dec;87(12):1286-306. Haematologica. 2002. PMID: 12495903

9

Hematologic passport for athletes competing in endurance sports: a feasibility study.

Malcovati L, Pascutto C, Cazzola M. Malcovati L, et al. Among authors: cazzola m. Haematologica. 2003 May;88(5):570-81. Haematologica. 2003. PMID: 12745277

10

Erythropoietin therapy: need for rationality and active surveillance.

Cazzola M. Cazzola M. Haematologica. 2003 Jun;88(6):601-5. Haematologica. 2003. PMID: 12801832 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,244 results

Search Page

Filters